Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic M Mercado, B Gonzalez, G Vargas, C Ramirez, ALE de los Monteros, ... The Journal of Clinical Endocrinology & Metabolism 99 (12), 4438-4446, 2014 | 211 | 2014 |
Are there really any predictive factors for a successful weight loss after bariatric surgery? D Cadena-Obando, C Ramírez-Rentería, A Ferreira-Hermosillo, ... BMC endocrine disorders 20, 1-8, 2020 | 122 | 2020 |
Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism AL Espinosa-de-los-Monteros, B González, G Vargas, E Sosa, M Mercado Pituitary 14, 231-235, 2011 | 75 | 2011 |
Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly M Mercado, B González, C Sandoval, Y Esquenazi, F Mier, G Vargas, ... The Journal of Clinical Endocrinology & Metabolism 93 (9), 3411-3415, 2008 | 70 | 2008 |
Giant prolactinomas: are they really different from ordinary macroprolactinomas? E Espinosa, E Sosa, V Mendoza, C Ramírez, V Melgar, M Mercado Endocrine 52, 652-659, 2016 | 68 | 2016 |
Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas I Shimon, E Sosa, V Mendoza, Y Greenman, A Tirosh, E Espinosa, ... Pituitary 19, 429-436, 2016 | 67 | 2016 |
Ectopic ACTH-secreting syndrome: a single center experience report with a high prevalence of occult tumor I Hernandez, AL Espinosa-de-los-Monteros, V Mendoza, S Cheng, ... Archives of Medical Research 37 (8), 976-980, 2006 | 62 | 2006 |
Adequate thyroid-stimulating hormone levels after levothyroxine discontinuation in the follow-up of patients with well-differentiated thyroid carcinoma R Sánchez, AL Espinosa-de-los-Monteros, V Mendoza, E Brea, ... Archives of medical research 33 (5), 478-481, 2002 | 62 | 2002 |
Discontinuation of octreotide LAR after long term, successful treatment of patients with acromegaly: is it worth trying? C Ramírez, G Vargas, B González, A Grossman, J Rábago, E Sosa, ... European Journal of Endocrinology 166 (1), 21-26, 2012 | 60 | 2012 |
Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status AL Espinosa‐de‐los‐Monteros, E Sosa, S Cheng, R Ochoa, C Sandoval, ... Clinical Endocrinology 64 (3), 245-249, 2006 | 58 | 2006 |
Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease M Mercado, AL Espinosa de los Monteros, E Sosa, S Cheng, V Mendoza, ... Hormone Research in Paediatrics 62 (6), 293-299, 2004 | 57 | 2004 |
GSPα mutations in Mexican patients with acromegaly: potential impact on long term prognosis V Mendoza, E Sosa, AL Espinosa-de-Los-Monteros, M Salcedo, G Guinto, ... Growth hormone & IGF research 15 (1), 28-32, 2005 | 44 | 2005 |
Efficacy and safety of radiotherapy in acromegaly B González, G Vargas, AL Espinosa-de-los-Monteros, E Sosa, M Mercado Archives of Medical Research 42 (1), 48-52, 2011 | 41 | 2011 |
Changing patterns of insulin-like growth factor—I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly AL Espinosa-De-Los-Monteros, M Mercado, E Sosa, O Lizama, G Guinto, ... Journal of neurosurgery 97 (2), 287-292, 2002 | 40 | 2002 |
Artículos de revisión. Diagnóstico y tratamiento actual de la hiperprolactinemia. V Melgar, E Espinosa, E Sosa, MJ Rangel, D Cuenca, C Ramírez, ... Revista Médica del Instituto Mexicano del Seguro Social, 2016 | 39* | 2016 |
Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors K Taniguchi-Ponciano, S Andonegui-Elguera, E Peña-Martínez, ... Scientific Reports 10 (1), 19373, 2020 | 38 | 2020 |
Treatment of multiresistant prolactinomas with a combination of cabergoline and octreotide LAR E Sosa-Eroza, E Espinosa, C Ramírez-Rentería, V Mendoza, R Arreola, ... Endocrine 61, 343-348, 2018 | 37 | 2018 |
Octreotide LAR treatment of acromegaly in “real life”: long-term outcome at a tertiary care center AL Espinosa-de-los-Monteros, B Gonzalez, G Vargas, E Sosa, M Mercado Pituitary 18, 290-296, 2015 | 36 | 2015 |
Long-term outcome of the different treatment alternatives for recurrent and persistent cushing disease AL Espinosa-de-Los-Monteros, E Sosa-Eroza, E Espinosa, V Mendoza, ... Endocrine Practice 23 (7), 759-767, 2017 | 34 | 2017 |
AIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience C Ramírez-Rentería, LC Hernández-Ramírez, L Portocarrero-Ortiz, ... Endocrine 53, 402-411, 2016 | 31 | 2016 |